Berger C

ORCID: 0000-0003-3595-0180 · 4 papers in corpus · active 2023-2026

Study types

  • other 1

Condition tags

  • endometriosis 1
  • chronic_pelvic_pain 1
2026
A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response.
EBioMedicine ·doi:10.1016/j.ebiom.2026.106135

BackgroundHigh-grade serous ovarian carcinoma (HGSOC) presents a significant therapeutic challenge. Late-stage disease is frequently associated with peritoneal carcinomatosis. The peritoneal metastases exhibit a unique tumour microenvironme…

other 2025
Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
Annals of medicine ·doi:10.1080/07853890.2025.2527352

BACKGROUND: Pelvic pain secondary to endometriosis is a disabling condition. There are multiple treatments available, with variable endpoints. No prospective controlled studies were carried out evaluating subdermal pellets of gestrinone in …

2024
Algorithm Training and Testing for a Nonendoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association ·doi:10.1016/j.cgh.2024.03.003

Background & aimsEndoscopic Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) detection is invasive and expensive. Nonendoscopic BE/EAC detection tools are guideline-endorsed alternatives. We previously described a 5-methylated D…

2023
Challenges in Permeability Assessment for Oral Drug Product Development.
Pharmaceutics ·doi:10.3390/pharmaceutics15102397

Drug permeation across the intestinal epithelium is a prerequisite for successful oral drug delivery. The increased interest in oral administration of peptides, as well as poorly soluble and poorly permeable compounds such as drugs for targ…